Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-072567
Filing Date
2024-06-18
Accepted
2024-06-18 07:17:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm242736d3_defa14a.htm DEFA14A 13307
2 GRAPHIC tm242736d3_defa14aimg001.jpg GRAPHIC 214798
3 GRAPHIC tm242736d3_defa14aimg002.jpg GRAPHIC 168970
  Complete submission text file 0001104659-24-072567.txt   543265
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37977 | Film No.: 241050176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)